A Dual-Fluorescence High-Throughput Cell Line System for Probing Multidrug Resistance
- 1 June 2009
- journal article
- research article
- Published by SAGE Publications in ASSAY and Drug Development Technologies
- Vol. 7 (3) , 233-249
Abstract
The efflux pump P-glycoprotein (ATP-binding cassette B1, multidrug resistance [MDR] 1, P-gp) has long been known to contribute to MDR against cancer chemotherapeutics. We describe the development of a dual-fluorescent cell line system to allow multiplexing of drug-sensitive and P-gp-mediated MDR cell lines. The parental OVCAR-8 human ovarian carcinoma cell line and the isogenic MDR NCI/ADR-RES subline, which stably expresses high levels of endogenous P-gp, were transfected to express the fluorescent proteins Discosoma sp. red fluorescent protein DsRed2 and enhanced green fluorescent protein, respectively. Co-culture conditions were defined, and fluorescent barcoding of each cell line allowed for the direct, simultaneous comparison of resistance to cytotoxic compounds in sensitive and MDR cell lines. We show that this assay system retains the phenotypes of the original lines and is suitable for multiplexing using confocal microscopy, flow cytometry, or laser scanning microplate cytometry in 1,536-well plates, enabling the high-throughput screening of large chemical libraries.Keywords
This publication has 39 references indexed in Scilit:
- The role of membrane transporters in drug delivery to brain tumorsCancer Letters, 2007
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- Plasma membrane calcium ATPase (PMCA4): A housekeeper for RT-PCR relative quantification of polytopic membrane proteinsBMC Molecular Biology, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- ABCG2 (BCRP): a cytoprotectant in normal and malignant stem cells.2006
- Predicting drug sensitivity and resistanceCancer Cell, 2004
- Karyotypic complexity of the NCI-60 drug-screening panel.2003
- Interaction of Imatinib Mesilate with Human P-GlycoproteinThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Specific inhibition of gene expression using a stably integrated, inducible small‐interfering‐RNA vectorEMBO Reports, 2003
- Actinomycin D causes multidrug resistance and differentiation in a human rhabdomyosarcoma cell line.1994